SkinBioTherapeutics’ technology, SkinBiotix®, shows positive results in cream formulation

05:37 EDT 17 Apr 2018 | Instinctif Partners

Skin Therapeutics

Manchester, UK – 17 April 2018 - SkinBioTherapeutics plc (AIM: SBTX,  the “Company”), a life science company focused on skin health, announces that the ‘cream’ formulation of its SkinBiotix® technology has passed effectiveness studies in models of skin. The cream formulation will now undergo further testing for stability in the coming weeks.

SkinBioTherapeutics’ platform, SkinBiotix®, utilises extracts of probiotic bacteria for application to the skin. The Company has shown in skin models that its technology can improve the skin’s barrier function (e.g. keep moisture in and protect skin from infection).

The cream has been formulated to contain SkinBioTherapeutics’ proprietary technology, SkinBiotix®. A crucial feature of the formulation phase is to test that the cream-SkinBiotix® combination retains the same beneficial properties as the original technology.

One important effect of SkinBiotix® in proof of concept studies was the increase of a specific skin protein essential to the barrier function of the skin. This effect was also shown when tested as a cream formulation. The data further showed a direct correlation between the amount of SkinBiotix® within the cream and the level of the protein present. Work on creating skin lotion and gel formulations is ongoing.

Dr Catherine O’Neill, CEO of SkinBioTherapeutics, commented:

“The incorporation of our SkInBiotix® technology into an effective cream formulation is a major milestone in the development of products for the cosmetic market and, subject to stability testing, allows us to create formulations for our human study later this year.”

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 and has been arranged for release by Doug Quinn, CFO of the Company.

- ENDS -

For more information, please contact:

SkinBioTherapeutics plc
Dr. Cath O’Neill, CEO
Doug Quinn, CFO
Tel: +44 (0) 161 468 2760

Cairn Financial Advisers LLP (Nominated Advisor)
Tony Rawlinson / Richard Nash
Tel: +44 (0) 20 7213 0880

Turner Pope Investments (Joint Broker)
Ben Turner / James Pope
Tel: +44 (0) 20 3621 4120

Northland Capital (Joint Broker)
John Howes / Tom Price
Tel: +44 (0) 20 3861 6625

Instinctif Partners
Melanie Toyne-Sewell / Deborah Bell

Tel: +44 (0) 20 7457 2020 / 074 9386 7443

Notes to Editors

About SkinBioTherapeutics plc
SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CEO Dr. Cath O’Neill and Professor Andrew McBain.

SkinBioTherapeutics’ platform applies research discoveries made on the activities of lysates derived from probiotic bacteria when applied to the skin.  The Company has shown that the SkinBiotix® platform can improve the barrier effect of skin models, protect skin models from infection and repair skin models.  Proof of principle studies have shown that the SkinBiotix® platform has beneficial attributes applicable to each of these areas.

SkinBioTherapeutics received seed funding from the Tech Transfer office of the University of Manchester for the discovery of SkinBiotix®. The platform was subsequently spun out of the University of Manchester in March 2016 and was funded by OptiBiotix PLC (AIM: OPTI).

The Company joined AIM in April 2017 concurrent with raising £4.5 million from a placing of new ordinary shares.

The Company is based in Manchester, UK. For more information, visit


More From BioPortfolio on "SkinBioTherapeutics’ technology, SkinBiotix®, shows positive results in cream formulation"

Quick Search


Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...

Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...